ID   PTPRN_HUMAN             Reviewed;         979 AA.
AC   Q16849; B4DK12; F5GZS3; Q08319; Q53QD6; Q6NSL1;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   10-MAY-2017, entry version 158.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase-like N;
DE            Short=R-PTP-N;
DE   AltName: Full=Islet cell antigen 512 {ECO:0000303|PubMed:8144912};
DE            Short=ICA 512 {ECO:0000303|PubMed:8641276};
DE   AltName: Full=Islet cell autoantigen 3;
DE   AltName: Full=PTP IA-2;
DE   Contains:
DE     RecName: Full=ICA512-N-terminal fragment;
DE              Short=ICA512-NTF;
DE   Contains:
DE     RecName: Full=ICA512-transmembrane fragment;
DE              Short=ICA512-TMF;
DE   Contains:
DE     RecName: Full=ICA512-cleaved cytosolic fragment;
DE              Short=ICA512-CCF;
DE   Flags: Precursor;
GN   Name=PTPRN; Synonyms=ICA3, ICA512;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Insulinoma;
RX   PubMed=8024693; DOI=10.1089/dna.1994.13.505;
RA   Lan M.S., Lu J., Goto Y., Notkins A.L.;
RT   "Molecular cloning and identification of a receptor-type protein
RT   tyrosine phosphatase, IA-2, from human insulinoma.";
RL   DNA Cell Biol. 13:505-514(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PRELIMINARY NUCLEOTIDE SEQUENCE OF 389-789, AND ROLE IN DIABETES
RP   MELLITUS.
RC   TISSUE=Pancreatic islet;
RX   PubMed=8144912;
RA   Rabin D.U., Pleasic S.M., Shapiro J.A., Yoo-Warren H., Oles J.,
RA   Hicks J.M., Goldstein D.E., Rae P.M.;
RT   "Islet cell antigen 512 is a diabetes-specific islet autoantigen
RT   related to protein tyrosine phosphatases.";
RL   J. Immunol. 152:3183-3188(1994).
RN   [7]
RP   SEQUENCE REVISION, AND ROLE IN DIABETES MELLITUS.
RX   PubMed=8641276;
RA   Solimena M., Dirkx R. Jr., Hermel J.-M., Pleasic-Williams S.,
RA   Shapiro J.A., Caron L., Rabin D.U.;
RT   "ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane
RT   protein of neurosecretory granules.";
RL   EMBO J. 15:2102-2114(1996).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10457160; DOI=10.1046/j.1460-9568.1999.00677.x;
RA   Hermel J.-M., Dirkx R., Solimena M.;
RT   "Post-translational modifications of ICA512, a receptor tyrosine
RT   phosphatase-like protein of secretory granules.";
RL   Eur. J. Neurosci. 11:2609-2620(1999).
RN   [9]
RP   INTERACTION WITH SNTB2, PROTEOLYTIC PROCESSING, AND PARTIAL PROTEIN
RP   SEQUENCE.
RX   PubMed=11483505; DOI=10.1093/emboj/20.15.4013;
RA   Ort T., Voronov S., Guo J., Zawalich K., Froehner S.C., Zawalich W.,
RA   Solimena M.;
RT   "Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated
RT   cleavage of ICA512 upon stimulation of insulin secretion.";
RL   EMBO J. 20:4013-4023(2001).
RN   [10]
RP   FUNCTION, INTERACTION WITH PIAS4, SUBCELLULAR LOCATION, AND
RP   PROTEOLYTIC CLEAVAGE.
RX   PubMed=15596545; DOI=10.1083/jcb.200408172;
RA   Trajkovski M., Mziaut H., Altkrueger A., Ouwendijk J., Knoch K.P.,
RA   Mueller S., Solimena M.;
RT   "Nuclear translocation of an ICA512 cytosolic fragment couples granule
RT   exocytosis and insulin expression in {beta}-cells.";
RL   J. Cell Biol. 167:1063-1074(2004).
RN   [11]
RP   INTERACTION WITH SNX19.
RX   PubMed=16273344; DOI=10.1007/s00125-005-0037-y;
RA   Hu Y.F., Zhang H.L., Cai T., Harashima S., Notkins A.L.;
RT   "The IA-2 interactome.";
RL   Diabetologia 48:2576-2581(2005).
RN   [12]
RP   FUNCTION, INTERACTION WITH STAT5B AND PIAS4, AND SUMOYLATION AT
RP   LYS-754.
RX   PubMed=16622421; DOI=10.1038/ncb1395;
RA   Mziaut H., Trajkovski M., Kersting S., Ehninger A., Altkrueger A.,
RA   Lemaitre R.P., Schmidt D., Saeger H.D., Lee M.S., Drechsel D.N.,
RA   Mueller S., Solimena M.;
RT   "Synergy of glucose and growth hormone signalling in islet cells
RT   through ICA512 and STAT5.";
RL   Nat. Cell Biol. 8:435-445(2006).
RN   [13]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=18824546; DOI=10.1074/jbc.M804928200;
RA   Trajkovski M., Mziaut H., Schubert S., Kalaidzidis Y., Altkrueger A.,
RA   Solimena M.;
RT   "Regulation of insulin granule turnover in pancreatic beta-cells by
RT   cleaved ICA512.";
RL   J. Biol. Chem. 283:33719-33729(2008).
RN   [14]
RP   FUNCTION.
RX   PubMed=18178618; DOI=10.1073/pnas.0710931105;
RA   Mziaut H., Kersting S., Knoch K.P., Fan W.H., Trajkovski M.,
RA   Erdmann K., Bergert H., Ehehalt F., Saeger H.D., Solimena M.;
RT   "ICA512 signaling enhances pancreatic beta-cell proliferation by
RT   regulating cyclins D through STATs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:674-679(2008).
RN   [15]
RP   FUNCTION.
RX   PubMed=20886068; DOI=10.1371/journal.pone.0012929;
RA   Schubert S., Knoch K.P., Ouwendijk J., Mohammed S., Bodrov Y.,
RA   Jaeger M., Altkrueger A., Wegbrod C., Adams M.E., Kim Y.,
RA   Froehner S.C., Jensen O.N., Kalaidzidis Y., Solimena M.;
RT   "beta2-Syntrophin is a Cdk5 substrate that restrains the motility of
RT   insulin secretory granules.";
RL   PLoS ONE 5:E12929-E12929(2010).
RN   [16]
RP   GLYCOSYLATION AT THR-441, STRUCTURE OF CARBOHYDRATES, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.M111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of
RT   N-and O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 0:0-0(2011).
RN   [17]
RP   FUNCTION.
RX   PubMed=24843546; DOI=10.1111/j.2040-1124.2011.00138.x;
RA   Harashima S., Horiuchi T., Wang Y., Notkins A.L., Seino Y.,
RA   Inagaki N.;
RT   "Sorting nexin 19 regulates the number of dense core vesicles in
RT   pancreatic beta-cells.";
RL   J. Diabetes Investig. 3:52-61(2012).
RN   [18]
RP   GLYCOSYLATION AT THR-441, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23234360; DOI=10.1021/pr300963h;
RA   Halim A., Ruetschi U., Larson G., Nilsson J.;
RT   "LC-MS/MS characterization of O-glycosylation sites and glycan
RT   structures of human cerebrospinal fluid glycoproteins.";
RL   J. Proteome Res. 12:573-584(2013).
RN   [19]
RP   SUBUNIT, SUBCELLULAR LOCATION, MUTAGENESIS OF ASN-506; ASN-524 AND
RP   GLY-553, AND GLYCOSYLATION AT ASN-506 AND ASN-524.
RX   PubMed=25561468; DOI=10.1128/MCB.00994-14;
RA   Torkko J.M., Primo M.E., Dirkx R., Friedrich A., Viehrig A.,
RA   Vergari E., Borgonovo B., Soenmez A., Wegbrod C., Lachnit M.,
RA   Muenster C., Sica M.P., Ermacora M.R., Solimena M.;
RT   "Stability of proICA512/IA-2 and its targeting to insulin secretory
RT   granules require beta4-sheet-mediated dimerization of its ectodomain
RT   in the endoplasmic reticulum.";
RL   Mol. Cell. Biol. 35:914-927(2015).
RN   [20]
RP   SUBUNIT, INTERACTION WITH INSULIN, AND DISULFIDE BONDS.
RX   PubMed=26836020; DOI=10.1016/j.bbapap.2016.01.013;
RA   Sosa L., Torkko J.M., Primo M.E., Llovera R.E., Toledo P.L.,
RA   Rios A.S., Flecha F.L., Trabucchi A., Valdez S.N., Poskus E.,
RA   Solimena M., Ermacora M.R.;
RT   "Biochemical, biophysical, and functional properties of ICA512/IA-2
RT   RESP18 homology domain.";
RL   Biochim. Biophys. Acta 1864:511-522(2016).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.23 ANGSTROMS) OF 681-979.
RX   PubMed=18058037; DOI=10.1007/s10969-007-9036-1;
RA   Almo S.C., Bonanno J.B., Sauder J.M., Emtage S., Dilorenzo T.P.,
RA   Malashkevich V., Wasserman S.R., Swaminathan S., Eswaramoorthy S.,
RA   Agarwal R., Kumaran D., Madegowda M., Ragumani S., Patskovsky Y.,
RA   Alvarado J., Ramagopal U.A., Faber-Barata J., Chance M.R., Sali A.,
RA   Fiser A., Zhang Z.Y., Lawrence D.S., Burley S.K.;
RT   "Structural genomics of protein phosphatases.";
RL   J. Struct. Funct. Genomics 8:121-140(2007).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 468-558.
RX   PubMed=18048354; DOI=10.1074/jbc.M708144200;
RA   Primo M.E., Klinke S., Sica M.P., Goldbaum F.A., Jakoncic J.,
RA   Poskus E., Ermacora M.R.;
RT   "Structure of the mature ectodomain of the human receptor-type
RT   protein-tyrosine phosphatase IA-2.";
RL   J. Biol. Chem. 283:4674-4681(2008).
CC   -!- FUNCTION: Plays a role in vesicle-mediated secretory processes
CC       (PubMed:24843546). Required for normal accumulation of secretory
CC       vesicles in hippocampus, pituitary and pancreatic islets (By
CC       similarity). Required for the accumulation of normal levels of
CC       insulin-containing vesicles and preventing their degradation
CC       (PubMed:24843546). Plays a role in insulin secretion in response
CC       to glucose stimuli (PubMed:24843546). Required for normal
CC       accumulation of the neurotransmitters norepinephrine, dopamine and
CC       serotonin in the brain (By similarity). In females, but not in
CC       males, required for normal accumulation and secretion of pituitary
CC       hormones, such as luteinizing hormone (LH) and follicle-
CC       stimulating hormone (FSH) (By similarity). Required to maintain
CC       normal levels of renin expression and renin release (By
CC       similarity). Seems to lack intrinsic enzyme activity (By
CC       similarity). May regulate catalytic active protein-tyrosine
CC       phosphatases such as PTPRA through dimerization (By similarity).
CC       {ECO:0000250|UniProtKB:Q60673, ECO:0000269|PubMed:24843546}.
CC   -!- FUNCTION: ICA512-transmembrane fragment: ICA512-TMF regulates
CC       dynamics and exocytosis of insulin secretory granules (SGs);
CC       binding of ICA512-TMF to SNTB2/beta-2-syntrophin is proposed to
CC       restrain SGs mobility and exocytosis by tethering them to the
CC       actin cytoskeleton depending on UTRN; the function is inhibited by
CC       cytoplasmic ICA512-CFF dimerizing with ICA512-TMF and displacing
CC       SNTB2. {ECO:0000269|PubMed:18824546, ECO:0000269|PubMed:20886068}.
CC   -!- FUNCTION: ICA512-cleaved cytosolic fragment: ICA512-CCF
CC       translocated to the nucleus promotes expression of insulin and
CC       other granule-related genes; the function implicates binding to
CC       and regulating activity of STAT5B probably by preventing its
CC       dephosphorylation and potentially by inducing its sumoylation by
CC       recruiting PIAS4 (PubMed:15596545, PubMed:16622421,
CC       PubMed:18178618). Enhances pancreatic beta-cell proliferation by
CC       converging with signaling by STAT5B and STAT3 (PubMed:15596545,
CC       PubMed:16622421, PubMed:18178618). ICA512-CCF located in the
CC       cytoplasm regulates dynamics and exocytosis of insulin secretory
CC       granules (SGs) by dimerizing with ICA512-TMF and displacing SNTB2
CC       thus enhancing SGs mobility and exocytosis (PubMed:18824546,
CC       PubMed:20886068). {ECO:0000269|PubMed:15596545,
CC       ECO:0000269|PubMed:16622421, ECO:0000269|PubMed:18178618,
CC       ECO:0000269|PubMed:18824546, ECO:0000269|PubMed:20886068}.
CC   -!- SUBUNIT: Homodimer; shown for the unprocessed protein (proICA512)
CC       in the endoplasmic reticulum and resolved during protein
CC       maturation as ICA512-TMF seems to be predominantly monomeric in
CC       secretory granules; however, ICA512-CCF interacts with ICA512-TMF
CC       disrupting the ICA512-TMF:SNTB2 complex. The isolated lumenal
CC       RESP18 homology domain has been shown to form disulfide-linked
CC       homooligomers (PubMed:25561468, PubMed:18824546, PubMed:26836020).
CC       Interacts (via cytoplasmic domain) with phosphorylated SNTB2; this
CC       protects PTPRN against cleavage by CAPN1 to produce ICA512-CCF.
CC       Dephosphorylation of SNTB2 upon insulin stimulation disrupts the
CC       interaction and results in PTPRN cleavage (PubMed:11483505).
CC       Interacts with SNX19 (PubMed:16273344). ICA512-CCF interacts with
CC       PIAS4; in the nucleus (PubMed:15596545). Interacts with STAT5B
CC       (phosphorylated); down-regulated by ICA512-CCF sumoylation;
CC       ICA512-CCF prevents STAT5B dephosphorylation; ICA512-CCF mediates
CC       interaction of STAT5B with PIAS4 (PubMed:15596545,
CC       PubMed:16622421). Interacts (via RESP18 homology domain) with
CC       insulin and proinsulin (PubMed:26836020). Interacts with PTPRN2,
CC       PTPRA and PTPRE (By similarity). {ECO:0000250|UniProtKB:Q60673,
CC       ECO:0000269|PubMed:11483505, ECO:0000269|PubMed:15596545,
CC       ECO:0000269|PubMed:16273344, ECO:0000269|PubMed:16622421,
CC       ECO:0000269|PubMed:18824546, ECO:0000269|PubMed:25561468,
CC       ECO:0000269|PubMed:26836020}.
CC   -!- INTERACTION:
CC       Q8WXG6:MADD; NbExp=4; IntAct=EBI-728153, EBI-310528;
CC       P21145:MAL; NbExp=3; IntAct=EBI-10200782, EBI-3932027;
CC       P60201:PLP1; NbExp=3; IntAct=EBI-10200782, EBI-8653150;
CC       P60201-2:PLP1; NbExp=5; IntAct=EBI-10200782, EBI-12188331;
CC       P62937:PPIA; NbExp=3; IntAct=EBI-728153, EBI-437708;
CC       Q13332:PTPRS; NbExp=5; IntAct=EBI-728153, EBI-711536;
CC       O14522:PTPRT; NbExp=3; IntAct=EBI-728153, EBI-728180;
CC       Q92543:SNX19; NbExp=4; IntAct=EBI-728153, EBI-728232;
CC       Q9H254:SPTBN4; NbExp=2; IntAct=EBI-728153, EBI-308543;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q63259};
CC       Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q63259}. Cytoplasmic vesicle, secretory
CC       vesicle membrane {ECO:0000305|PubMed:25561468}; Single-pass type I
CC       membrane protein {ECO:0000305}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q63259}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q63259}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q63259}. Cell membrane
CC       {ECO:0000269|PubMed:10457160}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q63259}. Endosome
CC       {ECO:0000250|UniProtKB:Q63259}. Note=Detected on neuronal
CC       secretory vesicles, but not on synaptic vesicles. Colocalizes with
CC       insulin-containing secretory granules (PubMed:25561468). Primarily
CC       detected on secretory vesicle membranes. Transiently found at the
CC       cell membrane, when secretory vesicles fuse with the cell membrane
CC       to release their cargo. Is then endocytosed and recycled to
CC       secretory vesicles via the Golgi apparatus membranes.
CC       {ECO:0000250|UniProtKB:Q63259, ECO:0000269|PubMed:25561468}.
CC   -!- SUBCELLULAR LOCATION: ICA512-transmembrane fragment: Cytoplasmic
CC       vesicle, secretory vesicle membrane
CC       {ECO:0000250|UniProtKB:Q63259}.
CC   -!- SUBCELLULAR LOCATION: ICA512-cleaved cytosolic fragment: Nucleus
CC       {ECO:0000269|PubMed:15596545}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q16849-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16849-2; Sequence=VSP_043654;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q16849-3; Sequence=VSP_045867;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expression is restricted to neuroendocrine
CC       cells. Found in pancreas, brain and pituitary.
CC       {ECO:0000269|PubMed:8024693}.
CC   -!- DOMAIN: The RESP18 homology domain is sufficient for targeting
CC       proICA512 to secretory granules. {ECO:0000269|PubMed:25561468}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:25561468}.
CC   -!- PTM: O-glycosylated with core 1 or possibly core 8 glycans.
CC       {ECO:0000269|PubMed:22171320, ECO:0000269|PubMed:23234360,
CC       ECO:0000269|PubMed:25561468}.
CC   -!- PTM: Subject to proteolytic cleavage at multiple sites
CC       (PubMed:11483505). Subject to cleavage on a pair of basic residues
CC       (By similarity). On exocytosis of secretory granules in pancreatic
CC       beta-cells ICA512-TMF is transiently inserted in the plasma-
CC       membrane and cleaved by mu-type calpain CPN1 to yield ICA512-CCF
CC       (By similarity). {ECO:0000250|UniProtKB:P56722,
CC       ECO:0000250|UniProtKB:Q63259, ECO:0000269|PubMed:11483505,
CC       ECO:0000305|PubMed:15596545}.
CC   -!- PTM: Sumoylated at two sites including Lys-754. Sumoylation
CC       decreases interaction with STAT5. {ECO:0000269|PubMed:16622421}.
CC   -!- DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus
CC       (IDDM). {ECO:0000269|PubMed:8144912, ECO:0000269|PubMed:8641276}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 8 subfamily. {ECO:0000305}.
CC   -!- CAUTION: Does not possess catalytic activity due to replacement of
CC       highly conserved residues in tyrosine-protein phosphatase domain.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L18983; AAA90974.1; -; mRNA.
DR   EMBL; AK296335; BAG59024.1; -; mRNA.
DR   EMBL; AC114803; AAY24038.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70724.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70726.1; -; Genomic_DNA.
DR   EMBL; BC070053; AAH70053.1; -; mRNA.
DR   EMBL; X62899; CAA44688.2; -; mRNA.
DR   CCDS; CCDS2440.1; -. [Q16849-1]
DR   CCDS; CCDS56167.1; -. [Q16849-3]
DR   CCDS; CCDS56168.1; -. [Q16849-2]
DR   PIR; I37577; I37577.
DR   RefSeq; NP_001186692.1; NM_001199763.1. [Q16849-2]
DR   RefSeq; NP_001186693.1; NM_001199764.1. [Q16849-3]
DR   RefSeq; NP_002837.1; NM_002846.3. [Q16849-1]
DR   UniGene; Hs.89655; -.
DR   PDB; 2I1Y; X-ray; 2.23 A; A/B=681-979.
DR   PDB; 2QT7; X-ray; 1.30 A; A/B=468-558.
DR   PDB; 3N01; X-ray; 1.30 A; A/B=470-558.
DR   PDB; 3N4W; X-ray; 1.45 A; A/B=470-558.
DR   PDB; 3NG8; X-ray; 1.35 A; A/B=470-558.
DR   PDB; 3NP5; X-ray; 1.80 A; A/B/C/D=470-558.
DR   PDBsum; 2I1Y; -.
DR   PDBsum; 2QT7; -.
DR   PDBsum; 3N01; -.
DR   PDBsum; 3N4W; -.
DR   PDBsum; 3NG8; -.
DR   PDBsum; 3NP5; -.
DR   ProteinModelPortal; Q16849; -.
DR   SMR; Q16849; -.
DR   BioGrid; 111762; 17.
DR   IntAct; Q16849; 12.
DR   MINT; MINT-1350221; -.
DR   STRING; 9606.ENSP00000295718; -.
DR   DEPOD; Q16849; -.
DR   iPTMnet; Q16849; -.
DR   PhosphoSitePlus; Q16849; -.
DR   UniCarbKB; Q16849; -.
DR   BioMuta; PTPRN; -.
DR   DMDM; 2499754; -.
DR   PaxDb; Q16849; -.
DR   PeptideAtlas; Q16849; -.
DR   PRIDE; Q16849; -.
DR   DNASU; 5798; -.
DR   Ensembl; ENST00000295718; ENSP00000295718; ENSG00000054356. [Q16849-1]
DR   Ensembl; ENST00000409251; ENSP00000386638; ENSG00000054356. [Q16849-2]
DR   Ensembl; ENST00000423636; ENSP00000392598; ENSG00000054356. [Q16849-3]
DR   GeneID; 5798; -.
DR   KEGG; hsa:5798; -.
DR   UCSC; uc002vkz.3; human. [Q16849-1]
DR   CTD; 5798; -.
DR   DisGeNET; 5798; -.
DR   GeneCards; PTPRN; -.
DR   HGNC; HGNC:9676; PTPRN.
DR   HPA; HPA007152; -.
DR   HPA; HPA007179; -.
DR   MIM; 601773; gene.
DR   neXtProt; NX_Q16849; -.
DR   OpenTargets; ENSG00000054356; -.
DR   PharmGKB; PA34021; -.
DR   eggNOG; KOG0793; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00870000136478; -.
DR   HOGENOM; HOG000243992; -.
DR   HOVERGEN; HBG053762; -.
DR   InParanoid; Q16849; -.
DR   KO; K07817; -.
DR   OMA; FLPYDHA; -.
DR   OrthoDB; EOG091G0LUR; -.
DR   PhylomeDB; Q16849; -.
DR   TreeFam; TF351976; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   ChiTaRS; PTPRN; human.
DR   EvolutionaryTrace; Q16849; -.
DR   GeneWiki; PTPRN; -.
DR   GenomeRNAi; 5798; -.
DR   PMAP-CutDB; Q16849; -.
DR   PRO; PR:Q16849; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000054356; -.
DR   CleanEx; HS_PTPRN; -.
DR   ExpressionAtlas; Q16849; baseline and differential.
DR   Genevisible; Q16849; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0043679; C:axon terminus; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030141; C:secretory granule; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0051020; F:GTPase binding; IEA:Ensembl.
DR   GO; GO:0030507; F:spectrin binding; IPI:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IDA:UniProtKB.
DR   GO; GO:0044389; F:ubiquitin-like protein ligase binding; IDA:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:1990502; P:dense core granule maturation; IGI:GO_Central.
DR   GO; GO:0030073; P:insulin secretion; IGI:GO_Central.
DR   GO; GO:0035773; P:insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0001553; P:luteinization; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:1904692; P:positive regulation of type B pancreatic cell proliferation; IDA:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0043627; P:response to estrogen; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0000302; P:response to reactive oxygen species; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR033522; IA-2/IA-2_beta.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR021613; Receptor_IA-2_dom.
DR   InterPro; IPR029403; RESP18_dom.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   PANTHER; PTHR19134:SF418; PTHR19134:SF418; 1.
DR   Pfam; PF11548; Receptor_IA-2; 1.
DR   Pfam; PF14948; RESP18; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Complete proteome; Cytoplasmic vesicle;
KW   Diabetes mellitus; Direct protein sequencing; Disulfide bond;
KW   Endosome; Glycoprotein; Isopeptide bond; Membrane; Nucleus;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Signal;
KW   Synapse; Transcription; Transcription regulation; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     34       {ECO:0000250}.
FT   CHAIN        35    979       Receptor-type tyrosine-protein
FT                                phosphatase-like N.
FT                                /FTId=PRO_0000025451.
FT   CHAIN        35    448       ICA512-N-terminal fragment.
FT                                {ECO:0000250|UniProtKB:P56722,
FT                                ECO:0000305|PubMed:26836020}.
FT                                /FTId=PRO_0000438079.
FT   CHAIN       449    979       ICA512-transmembrane fragment.
FT                                {ECO:0000250|UniProtKB:P56722,
FT                                ECO:0000305|PubMed:26836020}.
FT                                /FTId=PRO_0000438080.
FT   CHAIN       659    979       ICA512-cleaved cytosolic fragment.
FT                                {ECO:0000305|PubMed:15596545,
FT                                ECO:0000305|PubMed:26836020}.
FT                                /FTId=PRO_0000438081.
FT   TOPO_DOM     35    575       Lumenal. {ECO:0000255}.
FT   TRANSMEM    576    600       Helical. {ECO:0000255}.
FT   TOPO_DOM    601    979       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      709    969       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION       35    131       RESP18 homology domain.
FT   REGION      449    575       Sufficient for dimerization of proICA512.
FT                                {ECO:0000269|PubMed:25561468}.
FT   REGION      601    732       Sufficient for dimerization of proICA512.
FT                                {ECO:0000250|UniProtKB:P80560}.
FT   SITE        448    449       Cleavage. {ECO:0000250|UniProtKB:P56722}.
FT   MOD_RES     308    308       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60673}.
FT   CARBOHYD    441    441       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:22171320,
FT                                ECO:0000269|PubMed:23234360}.
FT   CARBOHYD    506    506       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:25561468}.
FT   CARBOHYD    524    524       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:25561468}.
FT   DISULFID     40     40       Interchain (with C-40 or C-47); in
FT                                multimeric form.
FT                                {ECO:0000305|PubMed:26836020}.
FT   DISULFID     47     47       Interchain (with C-40 or C-47); in
FT                                multimeric form.
FT                                {ECO:0000305|PubMed:26836020}.
FT   DISULFID     53     62       {ECO:0000305|PubMed:26836020}.
FT   CROSSLNK    754    754       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:16622421}.
FT   VAR_SEQ       1     90       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045867.
FT   VAR_SEQ     479    508       KPLSLAAGVKLLEILAEHVHMSSGSFINIS -> N (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043654.
FT   VARIANT     419    419       S -> R (in dbSNP:rs35314717).
FT                                /FTId=VAR_051762.
FT   MUTAGEN     506    506       N->A: Reduces N-glycosylation.
FT                                {ECO:0000269|PubMed:25561468}.
FT   MUTAGEN     524    524       N->A: Reduces N-glycosylation.
FT                                {ECO:0000269|PubMed:25561468}.
FT   MUTAGEN     553    553       G->D: Impairs normal processing and leads
FT                                to retention in the endoplasmic reticulum
FT                                and degradation.
FT                                {ECO:0000269|PubMed:25561468}.
FT   CONFLICT    673    673       S -> G (in Ref. 2; BAG59024).
FT                                {ECO:0000305}.
FT   STRAND      471    477       {ECO:0000244|PDB:2QT7}.
FT   HELIX       483    497       {ECO:0000244|PDB:2QT7}.
FT   HELIX       501    503       {ECO:0000244|PDB:2QT7}.
FT   STRAND      504    510       {ECO:0000244|PDB:2QT7}.
FT   STRAND      513    518       {ECO:0000244|PDB:2QT7}.
FT   HELIX       527    536       {ECO:0000244|PDB:2QT7}.
FT   HELIX       538    545       {ECO:0000244|PDB:2QT7}.
FT   STRAND      549    555       {ECO:0000244|PDB:2QT7}.
FT   HELIX       692    704       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       706    717       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       727    730       {ECO:0000244|PDB:2I1Y}.
FT   TURN        732    734       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       735    737       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       755    757       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      766    770       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      780    783       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       788    790       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       791    801       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      805    808       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      812    814       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      826    832       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      835    844       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      846    858       {ECO:0000244|PDB:2I1Y}.
FT   TURN        859    861       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      864    872       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      877    880       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       885    896       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      905    908       {ECO:0000244|PDB:2I1Y}.
FT   STRAND      910    913       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       914    930       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       938    946       {ECO:0000244|PDB:2I1Y}.
FT   HELIX       956    975       {ECO:0000244|PDB:2I1Y}.
SQ   SEQUENCE   979 AA;  105848 MW;  A852B9063D29399D CRC64;
     MRRPRRPGGL GGSGGLRLLL CLLLLSSRPG GCSAVSAHGC LFDRRLCSHL EVCIQDGLFG
     QCQVGVGQAR PLLQVTSPVL QRLQGVLRQL MSQGLSWHDD LTQYVISQEM ERIPRLRPPE
     PRPRDRSGLA PKRPGPAGEL LLQDIPTGSA PAAQHRLPQP PVGKGGAGAS SSLSPLQAEL
     LPPLLEHLLL PPQPPHPSLS YEPALLQPYL FHQFGSRDGS RVSEGSPGMV SVGPLPKAEA
     PALFSRTASK GIFGDHPGHS YGDLPGPSPA QLFQDSGLLY LAQELPAPSR ARVPRLPEQG
     SSSRAEDSPE GYEKEGLGDR GEKPASPAVQ PDAALQRLAA VLAGYGVELR QLTPEQLSTL
     LTLLQLLPKG AGRNPGGVVN VGADIKKTME GPVEGRDTAE LPARTSPMPG HPTASPTSSE
     VQQVPSPVSS EPPKAARPPV TPVLLEKKSP LGQSQPTVAG QPSARPAAEE YGYIVTDQKP
     LSLAAGVKLL EILAEHVHMS SGSFINISVV GPALTFRIRH NEQNLSLADV TQQAGLVKSE
     LEAQTGLQIL QTGVGQREEA AAVLPQTAHS TSPMRSVLLT LVALAGVAGL LVALAVALCV
     RQHARQQDKE RLAALGPEGA HGDTTFEYQD LCRQHMATKS LFNRAEGPPE PSRVSSVSSQ
     FSDAAQASPS SHSSTPSWCE EPAQANMDIS TGHMILAYME DHLRNRDRLA KEWQALCAYQ
     AEPNTCATAQ GEGNIKKNRH PDFLPYDHAR IKLKVESSPS RSDYINASPI IEHDPRMPAY
     IATQGPLSHT IADFWQMVWE SGCTVIVMLT PLVEDGVKQC DRYWPDEGAS LYHVYEVNLV
     SEHIWCEDFL VRSFYLKNVQ TQETRTLTQF HFLSWPAEGT PASTRPLLDF RRKVNKCYRG
     RSCPIIVHCS DGAGRTGTYI LIDMVLNRMA KGVKEIDIAA TLEHVRDQRP GLVRSKDQFE
     FALTAVAEEV NAILKALPQ
//
